Drug profile

The FDA adverse-event record for Rabies 3 Year Vaccine

19 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Rabies 3 Year Vaccine. See the species affected, top reactions, and outcomes below.

19
adverse-event reports
5.3%
death-coded share
Dog
most-reported species
4
Anaphylaxis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
1
Deaths Reported
5.3%
Death Rate

Active Ingredients

Rabies 3 Year Vaccine

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 18
Cat 1

Most Affected Breeds

Retriever - Labrador 5
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 1
Boxer (German Boxer) 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Bulldog 1
Coonhound (unspecified) 1
Spaniel - Cocker English 1
Shepherd Dog - Australian 1
Beagle 1
Terrier - Fox (unspecified) 1

Most Reported Reactions

Anaphylaxis 4
Vomiting 4
Lethargy (see also Central nervous system depression in Neurological) 3
Emesis (multiple) 3
Panting 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Discomfort NOS 2
Behavioural disorder NOS 2
Diarrhoea 2
Facial swelling (see also Skin) 2
Immune mediated haemolytic anaemia 2
Not himself/herself 2

Outcome Breakdown

Ongoing
11 (57.9%)
Recovered/Normal
6 (31.6%)
Outcome Unknown
1 (5.3%)
Euthanized
1 (5.3%)

Rabies 3 Year Vaccine Adverse Event Insights

19 reports name Rabies 3 Year Vaccine; 1 recorded a death outcome (5.3% of reported events, not a population-level mortality rate). Active ingredient: Rabies 3 Year Vaccine. Administration routes: Unknown, Subcutaneous.

By species: Dog (18 reports), Cat (1 reports). By breed: Retriever - Labrador (5), Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) (1), Boxer (German Boxer) (1).

Leading clinical signs: Anaphylaxis (4), Vomiting (4), Lethargy (see also Central nervous system depression in Neurological) (3), Emesis (multiple) (3). Outcome, 19 coded reports: Ongoing leads at 57.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.